Introduction
============

Years of research and discovery have proven that natural products have made significant contributions to new drug discovery for the treatment of cancer and infectious diseases, and valuable source of antioxidants ([@ref-23]; [@ref-27]).

There are numerous reactive species that are formed *in vivo* (classified as oxidising agents) that can lead to damaging DNA and biomolecules. Therefore, oxidative stress is considered as the main cause of development of degenerative diseases such as coronary heart disease, most cancers and ageing ([@ref-12]). In addition, various studies have confirmed that people deficient in antioxidative mechanisms are extra vulnerable to intense bacterial and fungal infections and HIV ([@ref-26]; [@ref-29]).

Cancer was classed as one cause of morbidity and mortality in 2012, affecting populations in all countries ([@ref-21]). Breast cancer is considered the most prevalent among women, whereas leukaemia is the most prevalent in those 12--25 years old. The main complication of leukaemia is infection ([@ref-13]; [@ref-15]). Therefore, cancer chemotherapy has become a major focus of research, worldwide. Natural products are important source for drug development due to the complex molecular structures of the active compounds, and they have the ability to interact with mammalian cell targets.

Piperaceae has a widely distributed pantropical family. The largest genera in the family are *Piper* with 2,000 species and *Peperomia* with 1,700 species ([@ref-11]). *Peperomia* has various uses in folk medicines, such as for the treatment of inflammation, gastric ulcers, asthma, pain and bacterial infection ([@ref-7]; [@ref-8]; [@ref-28]; [@ref-30]; [@ref-36]). Moreover, previous studies have reported *Peperomia* species to be rich in secondary metabolites. For example, twenty seven compounds were isolated from *P. vulcanica* and *P. fernandopoioana ([@ref-20]),* nineteen compounds from *P. sui* ([@ref-5]) and three novel secolignans from *P. blanda* (cultivated in Brazil) ([@ref-9]). In addition, sterols, two chromones and two C-glycosyl flavones were previously isolated from *P. blanda* ([@ref-32]) and showed modest antioxidant activity. Furthermore, two chromenes, separated from the aerial parts of the species, and tetrahydrofuran lignan have also been shown to have anti-trypanosomal properties. Therefore, presence of a large number of rare secolignans (peperomins, chromenes and polyketides of 2-acyl-cyclohexane-1,3-dione) make this genus a source of unique compounds.

*Peperomia blanda* is a herb species that is naturally distributed in Madagascar, Yemen, Macarena Island, Taiwan, Polynesia, Australia and also in Florida, USA to South America ([@ref-19]). *P. blanda,* cultivated on Socotra *Island* (Yemen), remains poorly studied. In this regard, the present study was designed to determine the chemical composition of *Peperomia blanda* (Jacq.) Kunth through the isolation of active components and assessment of their *in vitro* cytotoxic and antioxidant activities.

Material and Method
===================

Plant collection and extraction
-------------------------------

*Peperomia blanda* (Jacq.) Kunth was collected from the Socotra Island, Yemen (Diksam-sikand), with approval number 120025 and, 120026 from the General Directorate of Plant Protection, Yemen, and identified by Dr. Abdul Wali Al-Khulaidi, Department of Botany, Taiz University. The voucher specimen number PPLS/2013/90/1 was placed at the Faculty of Pharmacy, Sana'a University. Plant samples were oven-dried for 7 days at 30 °C. The dried sample was milled and stored at room temperature for further analysis. Dried plant sample weighing 50 g was successively extracted by Soxhlet extraction using solvents with different polarities, starting with non-polar petroleum ether, then dichloromethane and methanol. The resulting solvent extracts were concentrated under reduced pressure to obtain crude extracts for further biological studies and compound isolation. All solvents used were of analytical grade (Merck, Darmstadt, Germany).

Chemical profiling determination
--------------------------------

Chemical profiling of the different solvent extracts was carried out using gas chromatography mass spectrometer ([@ref-25]) QP2010 Plus (Shimadzu, Kyoto, Japan) with an auto sampler. The petroleum ether and dichloromethane extracts were dissolved in chloroform, and the methanol extract was dissolved in methanol, and 1 µL of each sample (100 µg/mL) was added to the column. A fused HP5-MS silica capillary column (30 m × 0.32 mm, film thickness 0.25 µm) was used. The carrier gas was helium, and 1:50 split ratio was used. The oven temperature was maintained at 50 °C for 5 min, after which it was slowly increased at a rate of 5 °C per min to 240 °C and maintained at 240 °C for 5 min. The injection port temperature was 250 °C and the spectra of the constituents of the sample solution were matched with the spectra of identified compounds kept in the internal library (Wiley; mass spectral library).

Isolation of compounds
----------------------

The *in vitro* cytotoxic and antioxidant assays of the crude solvent extracts were evaluated and showed activities. Therefore, to isolate bioactive compounds, petroleum ether and dichloromethane extracts were fractionated using column chromatography (50 × 3.5 cm) on silica gel and run with solvent gradients of chloroform:EtOAc (100:0, 95:5, 90:10, 85:5, 80:20, 75:25, 70:30 until 0:100 %v/v, each 400 mL), EtOAc:MeOH (100:0, 95:5, 90:10, 85:5, 80:20, 75:25, 70:30 until 0:100 %v/v, each 400 mL), and finally with 800 mL MeOH. A total of 200 sub-fractions (50 mL) were collected based on their TLC (8:2 of CHCl3:EtOAc, solvent system) into four main fractions of petroleum ether and three fractions of dichloromethane. Fraction 2 of the petroleum ether extract was further chromatographed with an n-hexane:EtOAc solvent system on silica gel to afford small needle crystals of *N,N*′-diphenethyloxamide and phytosterol mixture (stigmasterol and β-sitosterol). Dichloromethane fraction 2 was subjected to silica gel column chromatography for fractionation and purification using the gradient elution method with an n-hexane:EtOAc solvent system. Recrystallization was done by dissolving crystal in small amount of ethyl acetate and drops of hexane were added till turbid solution start to appear. Then solution left to dry and crystal start to form.

Structural elucidation
----------------------

Chemical structures of isolated compounds were elucidated using FT-IR/FT-FIR (Perkalin), GCMS (QP2010 Plus, Shimadzu, Kyoto, Japan) and 1D and 2D NMR (Nuclear Magnetic Resonance, JEOL, Peabody, MA, USA) spectroscopy at 500 MHz with deuterated chloroform as solvent. The crystal compounds were identified via single crystal X-ray structure determination (Oxford Diffraction Xcalibur Gemini S diffractometer; Agilent, Santa Clara, CA, USA) equipped with CuKα radiation, (*k* = 1.5418 Å). The data were processed using CrysAlis software and Empirical absorption correction using spherical harmonics was implemented using SCALE3 ABSPACK scaling algorithm ([@ref-35]). The figures were produced using MERCURY software ([@ref-17]).

Physical, chemical and spectroscopic data of the compounds
----------------------------------------------------------

### Peperomin A

White crystal, M.P = 154--157 °C. UV ^CHCl3^*λ*~max~ nm: 333, 294, 311. IR *ν*~max~ (CHCl~3~): 2958, 2870 (C-H), 1667 (C=C), 1462, 1389, 1220, 1190 (C-H) cm^−1^. The X-ray diffraction analysis, molecular formula (C~22~H~22~O~8~); EI-MS m/z: 414 (35), 315 (100), 299 (4), 285 (5). ^1^HNMR (CDCl~3~, 500 MHz) *δ* ppm: 6.41 (1H, *d, J* = 1*.95 Hz*, H-6′,6″), 6.33 (1H, *d, J* = 1*.95* Hz, H-2′,2″), 5.90-5.92 (2H, *d*, *J* = 2.00 Hz, 2 × OCH~2~O), 4.27 (1H, *m*, H-4a), 3.87 (3H, *s*, 2 × OCH~3~), 3.76 (1H, *m*, H-4b), 3.54 (1H, *d*, *J* = 10.9 Hz, H-5), 2.83 (1H, *m*, H-3), 2.31 (1H, *m*, H-2), 0.90 (3H, *d, J* = 8*.05* Hz, H-6). ^13^CNMR (CDCI~3~, 125MHz) *δ* ppm: 179.6 (C-1), 149.4 (C-3′), 149.3 (C-3″), 143.5 (C-5'), 143.6 (C-5″), 134.3 (C-4′), 136.1 (C-4″), 134. 4 (C-1′), 136.7 (C-1″), 107.7 (C-6′), 107.7 (C-6″), 101.6 (C-2′), 101.6 (C-2″), 101.1 (OCH~2~O), 101.3 (OCH~2~O), 70.3 (C-4), 56.0 (2 × OCH~3~), 56.2 (C-5), 47.1 (C-2), 40.2 (C-3), 15.8 (C-6).

### *N, N*′-diphenethyloxamide

Crystal needle. M.P = 184--185 °C UV ^CHCl3^*λ*~max~ nm: 290, 382. IR *ν*~max~ (CHCl~3~): 2993, 1635 (C=O), 1459, 1044 (C-H) 1364 (C-N). UPLC/Q-TOF-MS m/z \[M+1\]^+^ 296.300 (13.08), 235.1300 (25), 209.1200 (19), 123.0700 (14) (calcd for C~18~H~20~N~2~O~2~, 296.3628). ^1^HNMR (CDCl~3~, 500 MHz) *δ* ppm: 2.24 (2H, *m*, H-), 3.50 (2H, *m*, H-1′), 3.50 (1H, *m*, H-2′), 7.22 (3H, *m*, H-Ar). The X-ray diffraction analysis gave molecular formula (C~18~H~20~N~2~O~2~) and molecular mass 296.3 g/mol.

### Stigmasterol and β-sitosterol

White powder, percent of yield (0.04%), IR *ν*~max~ (CHCl~3~): 3200 (O--H,), 2870(C-H), 1667 (C=C), 1462, 1389, 1363, 1311, 1220, 1190 (C-H) cm-1. GCMS m/z 414.12 and 412.52 \[M+1\]^+^ (calc. for C~29~H~48~O = 412.69) (100), 351 (30), 255 (50), 55 (85) and (C29H50O=414.71) (40), 57(70), 43(100). ^1^HNMR (CDCl~3~, 500 MHz) *δ* ppm: 0.63 (3H, *s*, H-28), 5.14 (2H, *t*, *J* = 5.15 Hz, H-21), 4.98 (2H, *m*, H-20), 3.46 (1H, *m*, H-3), 1.19 (3H, *s*, H-29), 0.99 (3H, *d*, *J* = 2.85 Hz, H-19), 0.85 (3H, *t*, *J* = 5.15 Hz, H-24), 0.76 (3H, *d*, *J* = 2.9 Hz, H-26), 0.75 (3H, *d*, *J* = 1.15 Hz, H-27). ^13^C NMR (CDCl~3~, 125 MHz,) *δ* ppm: 140.8 (C-5), 138.4 (C-20), 129.3 (C-21), 121.8 (C-6), 71.8 (C-3), 56.8 (C-14), 56.0 (C-17), 50.2 (C-9), 45.8 (C-22), 42.2 (C-4), 40.6 (C-18), 39.7 (C-12), 36.5 (C-1), 31.9 (C-2), 31.7 (C-8), 30.3 (C-10), 30.3 (C-7), 29.2 (C-25), 29.0 (C-16), 25.5 (C-23), 24.4 (C-15), 21.1 (C-26), 21.1 (C-19), 19.4 (C-27), 18.8 (C-28), 12.1 (C-29), 12.0 (C-24).

Biological activity
-------------------

### Cytotoxicity assay using the colorimetric assay

*In vitro* cytotoxic potency of the investigated extracts was established using the colorimetric (MTT) assay. The three cancer cell lines involved were the human breast adenocarcinoma (MCF-7), murine myelomonocytic leukaemia (WEHI-3) and human promyelocytic leukaemia (HL-60). The three normal cell lines used were the human mammary epithelial cell line (MCF10A), primary dermal fibroblasts cell line (HDFa) and the human hepatic cell line (WRL-68). All cells were from American Type Culture Collection (ATCC) and were subcultured in tissue culture flask (75 cm) with RPMI1640 media mixed with 10% fetal bovine serum and 1% penicillin--streptomycin and kept in an incubator at 5% of CO~2~ saturation and 37 °C. The following solutions were prepared: crude extracts (dissolved in 1% DMSO) at various concentrations (100, 50, 25, 12.5, 6.3, 3.5, 1.5 and 0 µg/mL); and peperomin A, phytosterol mixture and standard drugs (Taxol and vinblastine) as positive controls at decreasing concentrations (50, 25, 12.5, 6.3, 3.5, 1.5, and 0 µg/mL). *N,N*′-diphenethyloxamide was not involved in the biological assay because of the low yield obtained. Extracts were incubated with the cancer cell lines for 72 h, and peperomin A and the phytosterol mixture were incubated for 24, 48 and 72 h. After the incubation periods, 20 µL of MTT solution (5 mg/mL) was added to each well and incubated for 4 h. To dissolve the formazan crystals formed, 100 µL of DMSO was added to each well. The IC~50~ values were calculated from the plot of cancer cell growth versus the concentration of extracts/compounds.

### Antioxidant assays

#### Free radical scavenging activity.

The free radical scavenging activities of the extracts, peperomin A and phytosterol mixture were estimated using the 1,1-diphenyl-2-picryl-hydrazyl (DPPH) assay. Quantitative estimation was done in 96-well ELISA plates in triplicate. Complete of 70 µL of DMSO was brought for each well followed by 100 µL of plant extract solution or isolated tested compounds. Various concentrations of each extract and peperomin A (15.6 --1,000 µg/mL) were used. Similar concentrations of ascorbic acid were used as positive control. A total of 30 µL DPPH (3.14 X 10^−3^ µM) was added to each well, then the plate was allowed to stand in the dark at 25 °C for 30 min, and the absorbance was later recorded taken at 517 nm. The free radical scavenging activity was calculated using the following equation: $$\documentclass[12pt]{minimal}
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}{}\begin{eqnarray*}\text{Free radical scavenging activity}(\text{%})=\nonumber\\\displaystyle \quad [(\text{Abs of DPPH}-\text{Abs of sample})/\text{Abs of DPPH}]\times 100\text{%}. \end{eqnarray*}\end{document}$$where Abs is absorbance. The relationship between each concentration and its scavenging percentage was plotted, and the IC~50~ value was calculated by interpolation. Scavenging activity was represented by IC~50~ values (the extract concentration that scavenges 50% of DPPH radicals).

### FRAP assay

The antioxidant power of *P. blanda* extracts by ferric reduction was done by preparing fresh FRAP reagent from acetate buffer (pH 3.6), a solution of 10 mM TPTZ (2,4,6-tri(2-pyridyl)-s-triazine) in 40 mM HCl and a solution of 20 mM iron (III) chloride in a ratio of 10:1:1 (%v/v) ([@ref-3]; [@ref-22]; [@ref-24]; [@ref-31]), butylated hydroxytoluene (BHT), and ascorbic acid were used as controls. Then, 10 µL of plant extracts, peperomin A, ferrous sulfate (standard) and the controls were added to 300 µL FRAP reagent (triplicate) in the dark and the absorbance was measured at 593 nm. A linear standard curve was constructed using 100 and 1,000 mM FeSO~4~. The results were represented as the ratio of the concentration of iron(III) mM over the extract dry weight (g).

Total phenolic and flavonoid contents determination
---------------------------------------------------

The total phenolic contents extracted were estimated by the Folin--Ciocalteu reagent ([@ref-25]; [@ref-34]). A seven-point standard curve (0--50 mg/L) for gallic acid (≥ 97%, GA) was built to calculate total phenolic percent as Gallic acid equivalent (mg GA/g dry extract). Analyses were performed in triplicates. The extract total flavonoid contents were evaluated based on the aluminum chloride colorimetric method ([@ref-34]; [@ref-35]), using quercetin as standard. Seven-point standard curve (0--1,000 mg/L) of quercetin was used and the levels of extracts total flavonoid content **were** calculated as quercetin equivalent (mg quercetin/g dry extract).

Results and Discussion
======================

Screening of plants for their medicinal values remains an important area in scientific research, and from the 1940s to 2014, 75% of the clinically approved small molecules originated, or were directly derived, from natural products ([@ref-27]). Therefore, in this study, *in vitro* cytotoxic and antioxidant activities of *P. blanda* were evaluated. Chemical profiling of crude solvent extracts was performed using GCMS, followed by isolation of bioactive compounds via column chromatography.

![GCMS chromatogram of (A) pet. ether extract, (B) DCM extract and (C) MeOH extract.](peerj-06-4839-g001){#fig-1}

Chemical profiling
------------------

The results obtained from GCMS investigation of the crude extracts led to the identification of several compounds. The different extracts showed 53--57 peaks ([Fig. 1](#fig-1){ref-type="fig"}).

The major peaks are summarized in [Table 1](#table-1){ref-type="table"} and the most commonly identified compounds were fatty acids, sesquiterpenes, palmitic acid, vitamins and steroids. Those compounds have been reported to have diverse biological activities, including antioxidant, antimicrobial, anticancer and anti-inflammatory activities ([@ref-25]). In addition, hydroquinone was identified, and has been reported to be used for the treatment of hyperpigmentation.

10.7717/peerj.4839/table-1

###### The major compounds detected in the different extracts of *P. blanda* by GCMS analysis.

![](peerj-06-4839-g004)

  Extracts     RT Minute                                                   Name of compound                           Molecular formula   Molecular weight (g/mol)   Peak area %             Compound nature                                                                          Activity
  ------------ ----------------------------------------------------------- ------------------------------------------ ------------------- -------------------------- ----------------------- ---------------------------------------------------------------------------------------- ----------
  MeOH         12.584                                                      4H-pyran-4-one                             C~6~H~8~O~4~        144                        5.05                    Central core of flavanoid                                                                
  33.238       n-Hexadecanoic acid                                         C~16~H~32~O~2~                             256                 2.39                       Palmitic acid           Antioxidant, Hypocholesterolemic, Nematicide, lubricant, flavor                          
  39.602       n-Nonadecanol-1                                             C~19~H~40~O                                284                 2.83                       Fatty alcohol           Antibacterial, anti-tubercular and cytotoxic activities                                  
  53.701       iso-propyl 5,9-hexacosadienoate                             C~29~H~54~O~2~                             392                 8.07                       Fatty acid              Antimicrobial                                                                            
  57.825       Pyrazole,(3-furyl)-1-(4-nitrophenyl)-5-phenyl-              C~6~H~8~O~4~                               331                 24.92                      Heterocyclic compound                                                                                            
  20.618       Caryophyllene                                               C~15~H~24~                                 204                 2.18                       Sesquiterpene           Anti-tumor, Analgesic, Anti-bacterial, Anti-inflammatory Sedative, Fungicide             
  33.281       n-Hexadecanoic acid                                         C~15~H~24~O                                256                 1.25                       Palmitic acid           Antioxidant, Hypocholesterolemic, Nematicide, lubricant, flavor                          
  50.799       2-cyclohexen-3,6diol-1-one2-tetradeconoyl                   C~17~H~36~O                                338                 1.86                                                                                                                                        
  51.964       Tetrapentacontane                                           C~17~H~32~O~2~                             758                 2.39                       Higher alkane           Lubricant, beewax                                                                        
  DCM          53.787                                                      (Phenylthio)acetic acid, hexadecyl ester   C~54~H~11~O         392                        14.25                                                                                                            
  55.556       Phen-1,3-diol,2-dodecanoyl                                  C~24~H~40~O~2~S                            292                 4.67                       Hydroquinone            Treatment of hyperpigmentation                                                           
  57.273       (Phenylthio)acetic acid, octadecyl ester                    C~60~H~122~                                420                 7.42                                                                                                                                        
  58.024       Vitamin E                                                   C~18~H~28~O~3~                             430                 20.8                       Vitamin compound        Antinflammatory, Antioxidant, Antidermatitic, Antileukemic, Antitumor, Anticancer        
  58.585       Gamma-sitosterol                                            C~29~H~50~O                                414                 4.61                       Steroid                 Hepatoprotective Antiasthma, Anti inflammatory Diuretic, Cancer preventive Antioxidant   
  20.605       Cyclohexane, 1-ethenyl-1-methyl-2,4-bis(1-methylethenyl)-   C~15~H~24~                                 204                 1.81                       Sesquiterpene           Anti-tumor, Analgesic, Anti-bacterial, Anti-inflammatory, Sedative, Fungicide            
  24.849       caryophyllene oxide                                         C~15~H~24~O                                220                 1.73                       Sesquiterpene                                                                                                    
  33.293       1-Hexadecanol, 2-methyl-                                    C~17~H~36~O                                256                 1.31                       Cetyl alcohol           Antimicrobial                                                                            
  36.233       Phytol                                                      C~20~H~40~O                                296                 2.82                       Diterpene               A manufacture precursor of synthetic form of vitamin E                                   
  37.073       cis-10-Heptadecenoic acid                                   C~17~H~32~O~2~                             268                 1.31                       Acetate                 No activity reported                                                                     
  51.979       Teterapentcontane                                           C~54~H~11~O                                758                 6.54                       Sesquiterpene           Anti-inflammatory and Antioxidant activities                                             
  Pet. ether   53.789                                                      (Phenylthio)acetic acid, hexadecyl ester   C~29~H~50~O         392                        12.81                                                                                                            
  54.773       Hexacontane                                                 C~15~H~24~                                 842                 7.29                       Saturated hydrocarbon                                                                                            
  55.561       Phen-1,3-diol,2-dodecanoyl                                  C~15~H~24~O                                292                 5.71                       Hydroquinone            Reducing agent, antioxidant                                                              
  57.253       Tetrapentacontane-1,40-diol                                 C~17~H~36~O                                420                 7.5                        Saponin                 Fragrance compounds                                                                      
  57.33        *β*-Sitosterol                                              C~29~H~48~O                                412                 4.24                       steroid                                                                                                          
  57.895       Vitamin E                                                   C~17~H~32~O~2~                             430                 2.81                       Vitamin                 Antidiabetic, Anti-inflammatory, Antioxidant, Antileukemic, Antitumor, Anticancer,       
  58.308       Teterapentcontane                                           C~54~H~11~O                                758                 4.87                       Sesquiterpene           Anti-inflammatory and antioxidant activities                                             
  58.58        Stigmasterol                                                C~29~H~50~O                                414                 6.10                                                                                                                                        

It can be seen from the data of GCMS in [Table 1](#table-1){ref-type="table"} that the presence of *N,N*′-diphenethyloxamide, *β*-sitosterol and stigmasterol with molecular ion peaks at 296, 414 and 412 (m/z), respectively, could be detected in petroleum ether with (peak number, retention time (RT)) values of (22, 36.23), (52, 57.33) and (56, 58.58) min. Moreover, GCMS analysis of the dichloromethane extract showed the presence of peperomin A with a molecular ion peak, peak number and RT of 414, 52 and 58.58 min, respectively.

Isolation of compounds
----------------------

The active petroleum ether and dichloromethane extracts of *P. blanda* were repeatedly chromatographed on silica gel and this successfully led to the isolation of three compounds ([Fig. 2](#fig-2){ref-type="fig"}), and the chemical structures were elucidated using 1D and 2D NMR, GCMS and X-ray diffraction for crystals obtained.

![The chemical structure of peperomin A (A), N,N′-diphenethyloxamide (B), Stigmasterol (C) and β-sitosterol (D).](peerj-06-4839-g002){#fig-2}

Single crystal X-ray structure determination
--------------------------------------------

Peperomin A was isolated in crystal form for the first time, and the X-ray crystal structure was deposited with the Cambridge Crystallographic Data Centre (CCDC) with deposition number CCDC 1529063. The structure of peperomin A was resolved in the centrosymmetric triclinic space group P 2~1~ 2~1~ 2~1~, with one molecule in the asymmetric unit ([Table 2](#table-2){ref-type="table"}). Lattice parameters have been determined as 11.3200 Å, b 11.6312 Å, c 14.5155 Å and the volume of the unit cell is found to be 1911.19 Å^3^. R-configuration is present at the chiral center C3 and S-configuration at the chiral center C5 of 2-methyl-butyl lactone ring. The x-ray molecular structure of peperomin A showed the same information found in solution by NMR spectroscopy that were also comparable with data reported by [@ref-9].

10.7717/peerj.4839/table-2

###### Crystal data and structure refinement for peperomin A and N,N′-Diphenethyloxamide.

![](peerj-06-4839-g005)

                                    Peperomin A                                  *N,N*′-Diphenethyloxamide
  --------------------------------- -------------------------------------------- ----------------------------------------
  Molecular formula                 C~22~H~22~O~8~                               C~18~H~20~N~2~O~2~
  Formula weight g/mol              414.40                                       296.36
  Temperature                       293 K                                        293 K
  Wavelength                        1.54178Å                                     1.54178 Å
  Crystal system                    Orthorhombic                                 Monoclinic
  Space group                       P2~1~2~1~2                                   P2~1~/c
  Unit cell parameters:                                                          
  *a/* Å                            11.3200(2)                                   10.6818(14)
  *b/* Å                            11.6312(2)                                   5.1688 (6)
  c/ Å                              14.5155 (3)                                  14.248 (2)
  *α*/°                             90                                           90
  *β*/°                             90                                           97.5(13)
  *γ*/°                             90                                           90
  Volume (Å^3^)                     1911.19(6)                                   779.90(18)
  Z                                 4                                            2
  Density (calculated)/gcm^−3^      1.440                                        1.262
  Absorption coefficient./µmm^−1^   0.926                                        0.663
  Crystal size (mm)                 0.3 × 0.25 × 0.25                            0.3 × 0.25 × 0.25
  Θ limits/°                        4.0370--36.3                                 4.5--37.5
  F (0000)                          872                                          316
  Index ranges                      −13 ≤ h ≤ 14,  − 14 ≤ k ≤ 13, −12 ≤ 1 ≤ 17   −13 ≤ h ≤ 12, −6 ≤ k ≤ 6, −16 ≤ 1 ≤ 17
  Reflection collected              5424                                         2793
  Independent reflections           3340 \[R~int~ = 0.0163\]                     1554 \[R~int~ = 0.0436\]
  Completeness to Θ = 36.3°         98.0 %                                       96.6 %
  Data /restrains /parameters       3340∕0∕271                                   1554∕0∕100
  Goodness of fit on F2             1.062                                        1.038
  R for I \>2 *α* (I)               R1 = 0.0318                                  R1 = 0.1091
  R for all data                    wR2 = 0.0803                                 wR2 = 0.2219
  Δ*ρ*~min~/e A^−3^                 −0.231                                       −0.483
  Δ*ρ*~max~/e A^−3^                 0.234                                        0.336

From 1D and 2D NMR data, it is apparent that ^1^H NMR spectrum displayed resonances of four meta-coupled aromatic hydrogens at 6.41 (H-6′,6″, *d*, *J* = 1.95 Hz), 6.33 (H-2′,2″, *J* = 1.5 Hz), two methylenedioxy groups at 5.90--5.92 (*d*, *J* = 1.2 Hz), and two O-methyl singlets at 3.87. This set of signals characterized two 3,4-methylenedioxy-5-methoxy phenyl rings with magnetically non-equivalent methylenedioxy protons as a result of the anisotrophy from aromatic ring ([@ref-9]). A doublet at *δ* 0.90 (H-6, *d*, *J* = 8.0 Hz) was assigned to the methyl group, and multiplets at 3.76 (H-4a) and 4.27 (H-4b) were due to the methylene group of the butyrolactone moiety. The resonances at *δ* 2.31 (H-2, m), 2.83 (H-3, m), and 3.54 (H-5, *d*, *J* = 10.9 Hz), due to three methine groups, were then observed. A Ϩ-butyrolactone ring was confirmed via HMBC between H-2, H- 4, and H-6 and the lactone carbonyl carbon at 179.9 ppm (C-1). The ^13^CNMR data corroborated the presence of the butyrolactone system, and all signals involved were accordingly assigned based on the HMBC data.

*N,N*′-diphenethyloxamide is a symmetric oxamide that have synthesized before to serve as a simple model for hydrogen bonding interaction that could be recoded in peptides and proteins ([@ref-18]). However to our knowledge, this is first time that it is isolated from the natural source. In this study, *N,N*′-diphenethyloxamide is the second crystal isolated for the first time from *Peperomia* species and the crystal structure was deposited with the CCDC with deposition number CCDC 1529062. The structure of *N,N*′-diphenethyloxamide ([Fig. 2](#fig-2){ref-type="fig"}) was resolved in the centrosymmetric monoclinic space group P 2~1~/c, as summarized in [Table 2](#table-2){ref-type="table"}. The crystal oxamide group has two independent amides that disregard a *π*-conjugation through the C-C central bond, as shown by the average bond length of the oxalyl (OC-CO) of 1.2306 Å and torsion angle value of −180.0 °, in comparison to the oxalyl (OC-CO) average bond length of 1.541 Å and torsion angle of 180.0 for a trans conformation of *N,N*′-bis(2-hydroxyphenyl)oxamide and torsional angle between 90--115° for other oxamide derivatives reported previously ([@ref-18]). In crystal packing, the nitrogen atoms (N and N′) of oxamide was hydrogen bonded to the oxygen atom of the carboxylic acids through N-H⋯O intermolecular interaction establishing a sheet along the axes ([Fig. 3](#fig-3){ref-type="fig"}) and the diffraction data details are summarized in [Table 2](#table-2){ref-type="table"}.

![Intermolecular interaction in the crystal structure packing of *N,N*′-diphenethyloxamide.](peerj-06-4839-g003){#fig-3}

The data for ^1^HNMR chemical shifts of Ar-CH~2~ and, CH~2~-N appeared at 2.24 and 3.50 ppm, and aryl hydrogen signals that are found at 7.22 ppm that are supported by previous data recorded for the synthesis of *N,N*′-diphenethyloxamide ([@ref-18]). UV absorption bands were obtained at 290, and 382 nm. The IR spectrum recorded the presence of different bands at 2993 to indicate the presence of NH group, and 1635 (C=O), 1459, 1044 (C-H) 1364 (C-N). These results are consistent with the data obtained from IR spectrum of synthesized *N,N*′-diphenethyloxamide that recorded IR *ν*~max~ (KBr)/cm^−1^ at 3,305, 1,653, 1,520, 1,495, 1,224, 1,189 and 697. Another important finding was the peak record from; UPLC/Q-TOF-MS m/z \[M+1\]^+^ at 296.300 for C~18~H~20~N~2~O~2~. The X-ray molecular structure of *N,N*′-diphenethyloxamide supported that data obtained from ^1^HNMR, IR, mass spectroscopy and the previous recorded study for the synthesized *N,N*′-diphenethyloxamide.

Biological activity
-------------------

Preliminary screening of the extracts using MTT assay showed cytotoxic activity against different cell lines. The petroleum ether extract exhibited IC~50~ values of 9.54 ± 0.30 and 4.3 ± 0.90 µg/mL against HL-60 and WEHI-3 cells, respectively. The dichloromethane extract showed IC~50~ values of 14.42 ± 1.52 and 15.58 ± 1.17 µg/mL against HL-60 and WEHI-3 cells, respectively. The methanol extract showed lower activity against HL-60 and WEHI-3 cell lines. However, methanol and petroleum ether extracts showed promising activity against MCF-7, with IC~50~ values of 10.49  ± 0.79 and 5.39 ± 0.34 µg/mL, respectively. The extracts showed low cytotoxicity against normal cells (MCF10A, WRL-68 and HDFa), with IC~50~ values greater than 100 µg/mL ([Table 3](#table-3){ref-type="table"}).
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###### IC~50~ (µ/mL) values of different extracts against various human cell lines.

![](peerj-06-4839-g006)

  Cell line   Pet. Ether extract                                    DCM extract                                           MeOH extract                                          Vinblastine    Paclitaxel
  ----------- ----------------------------------------------------- ----------------------------------------------------- ----------------------------------------------------- -------------- -----------------------------------------------------
  WEHI-3      4.3 ± 0.90                                            15.58 ± 1.17                                          104.39 ± 1.25                                         0.57 ± 0.035   ND
  HL-60       9.54 ± 0.30                                           14.42 ± 1.52                                          28.62 ± 2.19                                          5.00 ± 0.01    ND
  MCF-7       5.39 ± 0.34 (18.5)[^a^](#table-3fn2){ref-type="fn"}   30.56 ± 0.84 (3.2)[^a^](#table-3fn2){ref-type="fn"}   10.49 ± 0.79 (9.5)[^a^](#table-3fn2){ref-type="fn"}   ND             3.00 ± 0.07 (33.3)[^a^](#table-3fn2){ref-type="fn"}
  WRL68       \>100                                                 \>100                                                 \>100                                                 ND             ND
  HDFa        \>100                                                 \>100                                                 \>100                                                 ND             ND
  MCF10A      \>100                                                 \>100                                                 \>100                                                 ND             ND

**Notes.**

Ratio of the mean IC~50~ value deterfmined in the normal MCF10a cell line over the mean IC~50~ value determined in MCF-7 cancer cell line.

Only the selectivity indexes greater than one are referenced.

NDnot determined
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###### IC~50~ values of Peperomin A and phytosterol against various human cell lines.

![](peerj-06-4839-g007)

  Cell lines   Peperomin A          Phytosterol         Vinblastine         Paclitaxel                                                                                                                                     
  ------------ -------------------- ------------------- ------------------- ----------------------- ----------------------- ---------------------- -------------- ------------- ------------- -------------- ------------- -------------
  WEHI-3       20.09 ± 0.46         18.68 ± 0.73        4.62 ± 0.03         18.04 ± 0.58            12.93 ± 0.80            8.06 ± 0.16            4.11 ± 0.06    3.56 ± 0.07   0.57 ± 0.04   3.16 ± 0.02    2.15 ± 0.02   1.90 ± 0.9
  HL-60        43.62 ± 0.10         26.34 ± 0.26        16.36 ± 0.62        29.47 ± 0.80            13.29 ± 0.37            9.84 ± 0.61            5.91 ± 0.31    4.81 ± 0.19   2.36 ± 0.08   12.73 ± 0.40   8.67 ± 0.76   5.13 ± 0.32
  MCF-7        40.73 ± 0.92 (1.1)   9.22 ± 0.28 (1.3)   5.58 ± 0.47 (7.4)   30.69 ± 0.81 (1.62) b   15.21 ± 0.81 (3.28) b   8.94 ± 0.05 (5.59) b   14.58 ± 0.16   7.57 ± 0.50   5.16 ± 0.42   5.87 ± 0.19    4.47 ± 0.03   3.56 ± 0.34
  WRL68        \>50                 \>50                41.5 ± 0.54         \>50                    40.94 ± 0.29            37.27 ± 1.5            \>50           \>50          \>50          \>50           \>50          \>50
  HDFa         \>50                 \>50                \>50                \>50                    \>50                    49.42 ± 0.56           \>50           \>50          \>50          \>50           \>50          \>50
  MCF10A       \>50                 \>50                \>50                \>50                    \>50                    \>50                   \>50           \>50          \>50          \>50           \>50          \>50

**Notes.**

Mean and (standard) deviation calculated in triplicate.

Ratio of the mean IC~50~ value determined in the normal MCF10a cell line over the mean IC50 value determined in MCF-7 cell line.

Only the selectivity indexes greater than one are referenced.

NDnot determined

Peperomin A demonstrated cytotoxic activity against different tested cell lines with selectivity index values greater than 1 for cancer cells ([@ref-14]). Peperomin A exhibited cytotoxic activity against MCF-7 with an IC~50~ of 5.58 ± 0.47 µg/mL, compared to a standard drug, Taxol that has an IC~50~ of 3.00 ± 0.07 µg/mL ([Table 4](#table-4){ref-type="table"}). Moreover, peperomin A showed cytotoxic activity against HL-60 and WE-HI cells with IC~50~ values of 16.36 ± 0.62 and 4.62 ± 0.03 µg/mL, respectively. The isolated mixture of phytosterol (stigmasterol and *β*-sitosterol) showed anti-proliferative activity against WEHI-3, HL-60 and MCF-7, with IC~50~ values of 8.06 ± 0.16, 9.84 ± 0.61 and 8.94 ± 0.05 µg/L, respectively, as summarized in [Table 3](#table-3){ref-type="table"}. The *in vitro* cytotoxic activities of different solvent extracts of *P. blanda*, peperomin A and phytosterol reported herein are in accordance with previous reported studies in which, compounds such as secolignans and polyketides, previously isolated from *P. ducluoxii*, showed moderate growth inhibitory activity against VA-13 cells (malignant lung tumor cells) ([@ref-16]) and secolignans isolated from *P. pellucida*, inhibited the growth of HL-60 (human promyelocytic leukaemia), MCF-7 and HeLa (cervical cancer cells) ([@ref-36]). The secolognin and the polyketide isolated from *P. sui* showed cytotoxic activity against HONE-1 and NUGC-3 cell lines ([@ref-6]). Peperomin E showed anti-proliferative activity against human gastric carcinoma SGC-7901, BGC-823 and MKN-45 cell lines, and against non-small-cell lung cancer (NSCLC) cell lines. It also inhibited the proliferation of gastric cells by apoptosis induced via the mitochondrial and PI3K/Akt signalling pathways and exhibited anticancer activity in lung cancer by inhibiting DNMT1 expression and activity ([@ref-33]).

In addition, peperomin A and B showed moderate inhibitory effects on HIV-1 IIIB growth in C8166 cells (i.e., a cytopathic effect, CPE) and cytotoxic activity against the C8166 cell line. Previous studies have also reported the chemo protective activity of β-sitosterol in breast and colon cancer cell lines through inhibition of proliferation of the cancer cells, lowering the expression of β-catenin and PCNA, or activating Fas signaling ([@ref-1]; [@ref-2]; [@ref-4]).

Radical scavenging activity using the DPPH assay was tested for all extracts, peperomin A and phytosterol mixture. The inhibitory concentrations (IC~50~) are summarized in [Table 5](#table-5){ref-type="table"}.
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###### Antioxidant activity by DPPH, FRAP, TPC and TFC.

![](peerj-06-4839-g008)

                DPPH IC~50~ µg/mL   FRAP (M Fe(II)/g)   Total phenolic content (mg GAE/g)   Total flavonoid content (mg QE/g)
  ------------- ------------------- ------------------- ----------------------------------- -----------------------------------
  Pet. ether    203.80 ± 0.19       162.20 ± 0.80       16.42 ± 1.30                        214.30 ± 1.30
  DCM           61.78 ± 0.02        381.50 ± 1.31       22.52 ± 0.41                        232.00 ± 1.90
  MeOH          36.81 ± 0.09        287.00 ± 0.98       31.00 ± 0.44                        199.00 ± 1.70
  Phytosterol   620.15 ± 10.81      29.94 ± 0.43        ND                                  ND
  BHT           286.64 ± 8.54       1738.80 ± 9.53      ND                                  ND
  VIT C         20.40 ± 0.50        2603.90 ± 10.54     ND                                  ND
  Peperomin A   536.61 ± 6.00       20.79 ± 0.66        ND                                  ND

The methanol extract exhibited antioxidant activity with an IC~50~ of 36.81 ± 0.09 µg/mL, followed by the dichloromethane extract at 61.78 ± 0.02 µg/mL and 203.80 ± 0.19 µg/mL for the petroleum ether extract. The ferric reducing capability (FRAP) of the three crude extracts was also determined. The extracts exhibited weak ferric reducing ability ranging from 162.2 ± 0.80 to 381.5 ± 1.31 µg/mL, as compared to the standards, vitamin C and BHA, with values of 2603.96 ± 10.54 and 1738.8 ± 9.53 µg/mL, respectively ([Table 5](#table-5){ref-type="table"}).

The peperomin A and phytosterol mixture displayed weak free radical scavenging activity and ferric reducing power indicating that the antioxidant activity recorded in the crude extracts may be due to the presence of other secondary metabolites such as flavonoids and vitamin E that were observed from GCMS and analysis of flavonoid content in the crude extracts. Other reported compounds from *Peperomia*, such as two C-glycosyl-flavones isolated from *P. blanda* ([@ref-32]), phenylpropanoid, benzopyran, chromone, prenylated quinone, secolignan and acylcyclohexane-1, 3-dione could also be responsible for the antioxidant activities observed.

The total phenolic content ranged from 16.42 ± 1.30 mg GAE/g in the methanol extract to 31.00 ± 0.44 mg GAE/g in the petroleum ether extract ([Table 5](#table-5){ref-type="table"}). Moreover, the obtained results showed that total flavonoid content in the dichloromethane extract (232.0 ± 1.9 mg QE/100 g) was higher than in the petroleum ether extract (214.3 ± 1.3 mg QE/g) and the methanol extract (199.0 ± 1.7 mg QE/g). The phenol content varied due to the different solubility of phenol in each solvent extract. The more lipophilic phenols were extracted more readily in petroleum ether and dichloromethane, and their results were similar, while the polar phenols were more readily extracted by methanol. The phenol and flavonoid contents in each solvent extract led to different observations of antioxidant activities. Natural antioxidants like phenolic acids and flavonoids are interesting alternatives to modulate inflammation, and to inhibit the related oxidative processes ([@ref-10]). Consequently, further isolation of new flavonoids from this plant are warranted for drug discovery.

Conclusions
===========

The high activities shown by the extracts and the isolated compounds make this plant a valuable source for new anti-cancer drug development and herbal formulations. Further studies should be aimed at exploring and isolating novel bioactive compounds to be used as anti-cancer and anti-oxidizing agents.
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